Yahoo Finance Better Buy: Manulife Stock or Sun Life Stock?
Written by Andrew Walker at The Motley Fool Canada
Manulife (TSX:MFC) and Sun Life (TSX:SLF) are leaders in the TSX insurance sector. The stocks are moving higher after the March market correction, and investors are wondering if more gains could be on the way.
Manulife
Manulife has a current market capitalization near $48.5 billion. The stock trades around $26 per share at the time of writing. That’s up from $21 in November, but still below the 12-month high of about $27 the stock hit in early March before the financial sector crash sent the share price to $24.
Over the past five years, MFC stock is up about 7% and has bumped against a $27.50 ceiling several times. It will be interesting if the share price can break through that level this year.
Manulife gets its revenue from a broad range of services and across a global footprint. It operates insurance businesses in Canada and abroad under the Manulife brand and has a large wealth and asset management group operating as John Hancock, based in the United States.
Overseas, Manulife is growing its Asia business in an effort to capitalize on large populations with a growing middle class. As an example, Manulife bought out its 51% partner in TEDA Fund Management in mainland China last year.
The end of lockdowns in China and across Asia should help boost product sales in 2023.
Manulife delivered solid 2022 results. Adjusted net income came in at $7.3 billion, up marginally from 2021. Return on equity (ROE) was steady at about 14%. The company repurchased 4.1% of the outstanding stock last year and recently raised the dividend by 11% for 2023.
Investors who buy MFC stock at the current level can get a 5.6% dividend yield.
Sun Life
Sun Life has a current market capitalization of $38.3 billion. The stock trades near $65 per share at the time of writing. That’s up from $54 in October and not far off the $69 high it hit in February.
Over the past five years, SLF stock is up more than 20%. Sun Life has a similar footprint to Manulife, with insurance, wealth management, and asset management businesses primarily located in Canada, the United States, and Asia.
Underlying net income came in at $3.67 billion in 2022 compared to $3.53 billion the previous year. ROE remained above 15%. The board increased the quarterly dividend twice in 2022 for a total hike of $0.06 to $0.72 per share.
At the time of writing, investors can get a 4.4% yield on the stock.
Is one a better pick right now?
Insurance stocks are good alternatives to the banks for investors who are concerned that soaring interest rates could cause a crash in the housing market. In fact, rising interest rates tend to be positive for insurance companies, as they can get a better return on the cash they need to hold to cover potential claims.
Manulife offers a better yield than Sun Life right now. If you are focused on passive income, this might be the way to go as the first choice. Otherwise, Sun Life has delivered better share price growth in the past five years and should continue to raise the dividend, so it could be a good pick for investors targeting total returns.
The post Better Buy: Manulife Stock or Sun Life Stock? appeared first on The Motley Fool Canada.
Should You Invest $1,000 In Manulife?
Before you consider Manulife, you'll want to hear this.
Our market-beating analyst team just revealed what they believe are the 5 best stocks for investors to buy in April 2023... and Manulife wasn't on the list.
The online investing service they've run for nearly a decade, Motley Fool Stock Advisor Canada, is beating the TSX by 21 percentage points. And right now, they think there are 5 stocks that are better buys.
See the 5 Stocks * Returns as of 4/18/23
More reading
Brookfield Asset Management Spin-Off: What Investors Need to Know
Passive Income: 4 Safe Dividend Stocks to Own for the Next 10 Years
The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Fool contributor Andrew Walker has no position in any stock mentioned.
2023
